Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011.

Abstract:

:We have shown previously that EM011, a synthetic compound, binds tubulin with a higher affinity than the founding compound, noscapine, without changing total microtubule polymer mass. Now we show that EM011 is potently effective against vinblastine-resistant human lymphoblastoid line CEM/VLB100 and its parental vinblastine-sensitive line CEM. The cytotoxicity is mediated by cell cycle arrest at G2/M phase and subsequent apoptosis, as indicated by altered plasma membrane asymmetry, loss of mitochondrial transmembrane potential, activation of caspase-3, and increased DNA fragmentation. Furthermore, oral EM011 treatment of nude mice bearing human lymphoma xenografts results in pronounced tumor regression by triggering apoptosis and significantly lengthens the survival time of mice. EM011 treatment does not have obvious side effects in tissues with frequently dividing cells, such as the spleen and duodenum. In addition, EM011 does not show any toxicity in the liver, lung, heart, brain, and sciatic nerve. More importantly, EM011 does not affect hematopoiesis as determined by complete blood count profiles. These findings suggest that EM011 may be a safe and effective chemotherapeutic agent for oral treatment of drug-resistant human lymphomas.

journal_name

Blood

journal_title

Blood

authors

Aneja R,Zhou J,Vangapandu SN,Zhou B,Chandra R,Joshi HC

doi

10.1182/blood-2005-08-3516

subject

Has Abstract

pub_date

2006-03-15 00:00:00

pages

2486-92

issue

6

eissn

0006-4971

issn

1528-0020

pii

2005-08-3516

journal_volume

107

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.

    abstract::Ikaros plays an important role in the control of differentiation and proliferation of all lymphoid lineages. The expression of short isoforms lacking DNA-binding motifs alters the differentiation capacities of hematopoietic progenitors, arresting lineage commitment. We sought to determine whether molecular abnormaliti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-112631

    authors: Iacobucci I,Lonetti A,Messa F,Cilloni D,Arruga F,Ottaviani E,Paolini S,Papayannidis C,Piccaluga PP,Giannoulia P,Soverini S,Amabile M,Poerio A,Saglio G,Pane F,Berton G,Baruzzi A,Vitale A,Chiaretti S,Perini G,Foà R

    更新日期:2008-11-01 00:00:00

  • AU-rich RNA binding proteins in hematopoiesis and leukemogenesis.

    abstract::Posttranscriptional mechanisms are now widely acknowledged to play a central role in orchestrating gene-regulatory networks in hematopoietic cell growth, differentiation, and tumorigenesis. Although much attention has focused on microRNAs as regulators of mRNA stability/translation, recent data have highlighted the ro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-347237

    authors: Baou M,Norton JD,Murphy JJ

    更新日期:2011-11-24 00:00:00

  • Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

    abstract::The von Willebrand receptor complex, which is composed of the glycoproteins Ibα, Ibβ, GPV, and GPIX, plays an essential role in the earliest steps in hemostasis. During the last 4 decades, it has become apparent that loss of function of any 1 of 3 of the genes encoding these glycoproteins (namely, GP1BA, GP1BB, and GP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-08-732248

    authors: Sivapalaratnam S,Westbury SK,Stephens JC,Greene D,Downes K,Kelly AM,Lentaigne C,Astle WJ,Huizinga EG,Nurden P,Papadia S,Peerlinck K,Penkett CJ,Perry DJ,Roughley C,Simeoni I,Stirrups K,Hart DP,Tait RC,Mumford AD,NI

    更新日期:2017-01-26 00:00:00

  • Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

    abstract::Circulating endothelial progenitor cells (EPCs) are thought to contribute to angiogenesis following vascular injury, stimulating interest in their ability to mediate therapeutic angiogenesis. However, the number of EPCs in the blood is low, limiting endogenous repair, and a method to rapidly mobilize EPCs has not been...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-06-030577

    authors: Shepherd RM,Capoccia BJ,Devine SM,Dipersio J,Trinkaus KM,Ingram D,Link DC

    更新日期:2006-12-01 00:00:00

  • Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.

    abstract::Deletion of TP53 gene, under routine assessment by fluorescence in situ hybridization analysis, connects with the worst prognosis in chronic lymphocytic leukemia (CLL). The presence of isolated TP53 mutation (without deletion) is associated with reduced survival in CLL patients. It is unclear how these abnormalities a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-234708

    authors: Malcikova J,Smardova J,Rocnova L,Tichy B,Kuglik P,Vranova V,Cejkova S,Svitakova M,Skuhrova Francova H,Brychtova Y,Doubek M,Brejcha M,Klabusay M,Mayer J,Pospisilova S,Trbusek M

    更新日期:2009-12-17 00:00:00

  • Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

    abstract::Fibrin is essential for hemostasis; however, abnormal fibrin formation is hypothesized to increase thrombotic risk. We previously showed that in situ thrombin generation on a cell's surface modulates the 3-dimensional structure and stability of the fibrin network. Currently, we compared the abilities of extravascular ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-06-228940

    authors: Campbell RA,Overmyer KA,Selzman CH,Sheridan BC,Wolberg AS

    更新日期:2009-11-26 00:00:00

  • Identification and characterization of a differentiation antigen in human neutrophils and monocytes.

    abstract::Human promyelocytic leukemia (HL-60) cells were induced to differentiate into macrophage-like cells by treatment with 10(-7) mol/L 1,25-dihydroxyvitamin D3 (VD3). A monoclonal antibody (MoAb, 60B8), reactive with the particulate of the differentiated cells but not of the untreated cells, was isolated. The antigen reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nozawa R,Kato H,Ito T,Yokota T

    更新日期:1988-05-01 00:00:00

  • High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.

    abstract::Seventy-five patients with resistant acute leukemia or lymphoma received high-dose cyclophosphamide and etoposide to explore the activity of this combination in resistant hematologic malignancies, and to determine the maximum doses of these drugs that can be combined without bone marrow transplantation. Etoposide was ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brown RA,Herzig RH,Wolff SN,Frei-Lahr D,Pineiro L,Bolwell BJ,Lowder JN,Harden EA,Hande KR,Herzig GP

    更新日期:1990-08-01 00:00:00

  • Selective inhibition of the NLRP3 inflammasome by targeting to promyelocytic leukemia protein in mouse and human.

    abstract::The functional activities of the tumor suppressor promyelocytic leukemia protein (PML) are mostly associated with its nuclear location. In the present study, we discovered an unexpected role of PML in NLRP3 inflammasome activation. In PML-deficient macrophages, the production of IL-1β was strongly impaired. The expres...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-432104

    authors: Lo YH,Huang YW,Wu YH,Tsai CS,Lin YC,Mo ST,Kuo WC,Chuang YT,Jiang ST,Shih HM,Lai MZ

    更新日期:2013-04-18 00:00:00

  • Downregulation of the anti-HLA alloimmune response by variable region-reactive (anti-idiotypic) antibodies in leukemic patients transfused with platelet concentrates.

    abstract::Approximately 30% to 40% of patients with acute leukemia receiving repeated pooled random-donor platelet transfusions develop anti-HLA alloantibodies. Over time, however, serum anti-HLA concentrations decrease in approximately 50% of these patients, despite continued exposure to platelet and/or red blood cell transfus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Atlas E,Freedman J,Blanchette V,Kazatchkine MD,Semple JW

    更新日期:1993-01-15 00:00:00

  • Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.

    abstract::The majority of diffuse large B-cell lymphoma (DLBCL) tumors contain mutations in histone-modifying enzymes (HMEs), indicating a potential therapeutic benefit of histone deacetylase inhibitors (HDIs), and preclinical data suggest that HDIs augment the effect of rituximab. In this randomized phase 2 study, we evaluated...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2016-02-699520

    authors: Assouline SE,Nielsen TH,Yu S,Alcaide M,Chong L,MacDonald D,Tosikyan A,Kukreti V,Kezouh A,Petrogiannis-Haliotis T,Albuquerque M,Fornika D,Alamouti S,Froment R,Greenwood CM,Oros KK,Camglioglu E,Sharma A,Christodoulopoul

    更新日期:2016-07-14 00:00:00

  • Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

    abstract::Hepatitis C virus (HCV) is associated with the B-cell lymphoproliferative disorders mixed cryoglobulinemia (MC) and non-Hodgkin lymphoma. We have previously reported that HCV(+)MC(+) patients have clonal expansions of hypermutated, rheumatoid factor-bearing marginal zone-like IgM(+)CD27(+) peripheral B cells using the...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2010-10-312942

    authors: Charles ED,Brunetti C,Marukian S,Ritola KD,Talal AH,Marks K,Jacobson IM,Rice CM,Dustin LB

    更新日期:2011-05-19 00:00:00

  • How I treat childhood CML.

    abstract::Chronic myeloid leukemia (CML) is composed of 3% of pediatric leukemias, making evidence-based recommendations difficult. Imatinib has revolutionized the treatment for adult CML by eliminating allogeneic stem cell transplantation for almost all patients in chronic phase. Shown effective in pediatric CML, imatinib and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-380774

    authors: Andolina JR,Neudorf SM,Corey SJ

    更新日期:2012-02-23 00:00:00

  • High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

    abstract::Single-center experiences have shown that intensified treatments with autologous transplantation are a promising therapeutic strategy for patients with high-risk follicle-center lymphoma (FCL) at diagnosis, whereas data from prospective multicenter trials are still lacking. This paper describes the results of a prospe...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2002-02-0621

    authors: Ladetto M,Corradini P,Vallet S,Benedetti F,Vitolo U,Martelli M,Brugiatelli M,Coser P,Perrotti A,Majolino I,Fioritoni G,Morandi S,Musso M,Zambello R,Chisesi T,Di Renzo N,Vivaldi P,De Crescenzo A,Gallamini A,Salvi F,

    更新日期:2002-09-01 00:00:00

  • Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche.

    abstract::Stem cell localization, conservation, and differentiation is believed to occur in niches in the marrow stromal microenvironment. Our recent observation that long-term in vitro human hematopoiesis requires a stromal heparan sulfate proteoglycan (HSPG) led us to hypothesize that such HSPG may orchestrate the formation o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gupta P,Oegema TR Jr,Brazil JJ,Dudek AZ,Slungaard A,Verfaillie CM

    更新日期:1998-12-15 00:00:00

  • Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.

    abstract::Endothelial progenitor cell (EPC) mobilization has been reported following tissue damage, whereas no data are available regarding the mobilization of hematopoietic progenitor cells (HPCs). We performed the phenotypic and functional analysis of circulating CD34+ progenitor cells in patients with acute myocardial infarc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-1831

    authors: Massa M,Rosti V,Ferrario M,Campanelli R,Ramajoli I,Rosso R,De Ferrari GM,Ferlini M,Goffredo L,Bertoletti A,Klersy C,Pecci A,Moratti R,Tavazzi L

    更新日期:2005-01-01 00:00:00

  • Treatment of paroxysmal nocturnal hemoglobinuria.

    abstract::Patients with PNH may be treated with a number of known agents. As in all patients with a chronic disease, a regimen tolerable over a long period of time must be selected. Knowledge and anticipation of complications and their proper treatment are essential parts in the treatment. When these principals are used, many p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rosse WF

    更新日期:1982-07-01 00:00:00

  • Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

    abstract::A cohort of MDS patients was examined for mutations affecting 4 splice genes (SF3B1, SRSF2, ZRSR2, and U2AF35) and evaluated in the context of clinical and molecular markers. Splice gene mutations were detected in 95 of 221 patients. These mutations were mutually exclusive and less likely to occur in patients with com...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-400994

    authors: Damm F,Kosmider O,Gelsi-Boyer V,Renneville A,Carbuccia N,Hidalgo-Curtis C,Della Valle V,Couronné L,Scourzic L,Chesnais V,Guerci-Bresler A,Slama B,Beyne-Rauzy O,Schmidt-Tanguy A,Stamatoullas-Bastard A,Dreyfus F,Prébet T,

    更新日期:2012-04-05 00:00:00

  • Mechanisms of resistance to high and low linear energy transfer radiation in myeloid leukemia cells.

    abstract::Low linear energy transfer (LET) ionizing radiation (IR) is an important form of therapy for acute leukemias administered externally or as radioimmunotherapy. IR is also a potential source of DNA damage. High LET IR produces structurally different forms of DNA damage and has emerged as potential treatment of metastati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-404509

    authors: Haro KJ,Scott AC,Scheinberg DA

    更新日期:2012-09-06 00:00:00

  • Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

    abstract::The use of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) following autologous marrow transplantation for lymphoid malignancies was explored in a phase I/II dose escalation study. rhGM-CSF given as a 2-hour infusion daily for 14 days was well tolerated at doses up to 240 micrograms/m2/da...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nemunaitis J,Singer JW,Buckner CD,Hill R,Storb R,Thomas ED,Appelbaum FR

    更新日期:1988-08-01 00:00:00

  • Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes.

    abstract::We previously showed the presence of receptors for granulocyte-macrophage colony-stimulating factor (GM-CSF) on tumor tissues and tumor cell lines that are derived from the neural crest. To determine whether normal neural cells express functional GM-CSF receptors, we isolated and analyzed primary rat brain cells, incl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Baldwin GC,Benveniste EN,Chung GY,Gasson JC,Golde DW

    更新日期:1993-12-01 00:00:00

  • Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro.

    abstract::Deferoxamine (DF) has antimalarial activity that can be demonstrated in vitro and in vivo. This study is designed to examine the speed of onset and stage dependency of growth inhibition by DF and to determine whether its antimalarial activity is cytostatic or cytocidal. Growth inhibition was assessed by suppression of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Whitehead S,Peto TE

    更新日期:1990-09-15 00:00:00

  • Translation of the Philadelphia chromosome into therapy for CML.

    abstract::Throughout its history, chronic myeloid leukemia (CML) has set precedents for cancer research and therapy. These range from the identification of the first specific chromosomal abnormality associated with cancer to the development of imatinib as a specific, targeted therapy for the disease. The successful development ...

    journal_title:Blood

    pub_type: 历史文章,杂志文章,评审

    doi:10.1182/blood-2008-07-077958

    authors: Druker BJ

    更新日期:2008-12-15 00:00:00

  • Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells.

    abstract::Although recent data suggests that osteoblasts play a key role within the hematopoietic stem cell (HSC) niche, the mechanisms underpinning this remain to be fully defined. The studies described herein examine the role in hematopoiesis of Osteopontin (Opn), a multidomain, phosphorylated glycoprotein, synthesized by ost...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4422

    authors: Nilsson SK,Johnston HM,Whitty GA,Williams B,Webb RJ,Denhardt DT,Bertoncello I,Bendall LJ,Simmons PJ,Haylock DN

    更新日期:2005-08-15 00:00:00

  • alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.

    abstract::The Aalpha-fibrinogen Thr312Ala polymorphism, which occurs in a region involved in factor XIII (FXIII)-dependent cross-linking processes, is associated with poststroke mortality in subjects with atrial fibrillation, suggesting an influence either on intraatrial clot formation or embolization. We have determined the as...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carter AM,Catto AJ,Kohler HP,Ariëns RA,Stickland MH,Grant PJ

    更新日期:2000-08-01 00:00:00

  • Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron.

    abstract::In 33 patients with thalassemia and idiopathic hemochromatosis, plasma ferritin protein levels ranged from 36 to 5,850 micrograms/L. The iron content of this ferritin as determined by immunoprecipitation ranged from undetectable amounts to 507 micrograms/L. The mean iron content of ferritin protein in those and other ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pootrakul P,Josephson B,Huebers HA,Finch CA

    更新日期:1988-04-01 00:00:00

  • FCR achieves long-term durable remissions in patients with IGHV-mutated CLL.

    abstract::In chronic lymphocytic leukemia (CLL) patients with mutated IGHV, 3 recent studies have demonstrated prolonged progression-free survival (PFS) after treatment with fludarabine-cyclophosphamide-rituximab (FCR) chemoimmunotherapy. We performed a systematic review to assess the benefit of FCR for patients with CLL and id...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-07-731588

    authors: Chai-Adisaksopha C,Brown JR

    更新日期:2017-11-23 00:00:00

  • Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain.

    abstract::Factor XIII is the fibrin-stabilizing factor that covalently cross-links fibrin monomers to form a highly organized, stable fibrin clot. The plasma form of factor XIII is a heterodimer, a2b2, consisting of two a-chains and two b-chains; the intracellular form, such as in platelets and placenta, is a dimer, a2, consist...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weisberg LJ,Shiu DT,Conkling PR,Shuman MA

    更新日期:1987-08-01 00:00:00

  • Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific.

    abstract::Human subjects maintain long-term immunologic memory against infective organisms but the mechanism is unclear. CD4+ T-helper memory (Thmem) cells are pivotal in controlling humoral and cellular responses, therefore their longevity and response to vaccination are critical for maintenance of protective immunity. To prob...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-08-3255

    authors: Di Genova G,Roddick J,McNicholl F,Stevenson FK

    更新日期:2006-04-01 00:00:00

  • Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.

    abstract::Anaplastic large cell lymphoma (ALCL) is composed of large, frequently bizarre, cells of T- or null-cell phenotype that show a preferential sinusoidal growth pattern and consistent CD30 positivity. Whether these tumors represent a single entity or several, and what the exact cell origin, is controversial. Recently, gr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Krenacs L,Wellmann A,Sorbara L,Himmelmann AW,Bagdi E,Jaffe ES,Raffeld M

    更新日期:1997-02-01 00:00:00